Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00178581
Status:
TERMINATED
Last Update Posted:
2010-04-23
First Post:
2005-09-12
Brief Title:
Enteral Glutamine Supplementation for the Patient With Major Torso Trauma
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Study Overview
Official Title:
Early Enteral Glutamine Supplement to Enteral Nutrition Support of the Major Torso Trauma Patient Proposal for a Prospective Randomized Clinical Trial
Status:
TERMINATED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Glutamine is considered a conditionally essential amino acid during critical illness After severe trauma glutamine supplementation into the gastrointestinal tract may help maintain bowel function We hypothesize that for the major torso trauma patient high dose glutamine given enterally during resuscitation from shock and continued during enteral nutrition support is absorbed available systemically and preserves gut integrity
Detailed Description:
In this prospective randomized controlled trial of patients with major torso trauma high-dose enteral glutamine and enteral nutrition will be given to research subjects while controls will receive isocaloric isonitrogenous enteral support Enteral tolerance bowel integrity and permeability will be evaluated The systemic appearance of glutamine will be measured
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| M01RR002558 | NIH | None | httpsreporternihgovquickSearchM01RR002558 |